Genome-wide gene expression studies from human peripheral blood related to RSV infection
| Reference | GEO number | Platform | Condition 1 (sample size) | Condition 2 (sample size) |
| Reference group | ||||
| Brand et al 17 | GSE69606 | GPL570 | RSV infection acute phase: severe cases (n=6) | RSV infection recovery phase: severe cases (n=8) |
| RSV infection acute phase: moderate cases (n=9) | RSV infection recovery phase: moderate cases (n=9) | |||
| Mejias et al 18 | GSE38900 | GPL10558 | RSV infection acute phase (n=28) | Healthy controls (n=8) |
| GPL6884 | RSV infection acute phase (n=107) | Healthy controls (n=31) | ||
| Herberg et al 19 | GSE42026 | GPL6947 | RSV infection acute phase (n=22) | Healthy controls (n=33) |
| Ioannidis et al 20 | GSE34205 | GPL570 | RSV infection acute phase (n=51) | Healthy controls (n=11) |
| Zaas et al 21 | GSE17156 | GPL571 | RSV infection acute phase (n=20) | RSV infection recovery phase (n=20) |
GEO, Gene Expression Omnibus; RSV, respiratory syncytial virus.